(Q34686851)

English

Indacaterol on dyspnea in chronic obstructive pulmonary disease: a systematic review and meta-analysis of randomized placebo-controlled trials

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

4 references

17 September 2019

7 November 2019

13 November 2019

26 November 2020

0 references

Indacaterol on dyspnea in chronic obstructive pulmonary disease: a systematic review and meta-analysis of randomized placebo-controlled trials (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

0 references

heterocyclic compound

1 reference

17 September 2019

chronic obstructive pulmonary disease

4 references

17 September 2019

7 November 2019

13 November 2019

26 November 2020

1 reference

7 November 2019

polycyclic compound

1 reference

13 November 2019

1 reference

26 November 2020

systematic review

1 reference

based on heuristic

inferred from title

3

object named as

Nanshan Zhong

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

author name string

Jiangna Han

1

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Lu Dai

2

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

publication date

25 April 2013

5 references

Europe PubMed Central

PubMed publication ID

3 August 2017

17 September 2019

7 November 2019

13 November 2019

26 November 2020

BMC Pulmonary Medicine

5 references

Europe PubMed Central

PubMed publication ID

3 August 2017

17 September 2019

7 November 2019

13 November 2019

26 November 2020

13

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

26

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

copyright license

Creative Commons Attribution 2.0 Generic

4 references

Europe PubMed Central

17 September 2019

Europe PubMed Central

7 November 2019

Europe PubMed Central

13 November 2019

Europe PubMed Central

26 November 2020

copyright status

0 references

Long-acting beta-agonists and their association with inhaled corticosteroids in COPD.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3651265

7 July 2018

Efficacy and tolerability of indacaterol 75 μg once daily in patients aged ≥40 years with chronic obstructive pulmonary disease: results from 2 double-blind, placebo-controlled 12-week studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3651265

7 July 2018

Therapeutic potential for novel ultra long-acting β2-agonists in the management of COPD: biological and pharmacological aspects.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3651265

7 July 2018

Diagnosis and Management of Stable Chronic Obstructive Pulmonary Disease: A Clinical Practice Guideline Update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3651265

7 July 2018

Characterization of the bronchodilatory dose response to indacaterol in patients with chronic obstructive pulmonary disease using model-based approaches

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3651265

7 July 2018

Indacaterol provides 24-hour bronchodilation in COPD: a placebo-controlled blinded comparison with tiotropium.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3651265

7 July 2018

Onset of action of indacaterol in patients with COPD: comparison with salbutamol and salmeterol-fluticasone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3651265

7 July 2018

Efficacy of a new once-daily long-acting inhaled beta2-agonist indacaterol versus twice-daily formoterol in COPD.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3651265

7 July 2018

Once-daily bronchodilators for chronic obstructive pulmonary disease: indacaterol versus tiotropium

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3651265

7 July 2018

American College of Chest Physicians consensus statement on the management of dyspnea in patients with advanced lung or heart disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3651265

7 July 2018

Integrating indacaterol dose selection in a clinical study in COPD using an adaptive seamless design

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3651265

7 July 2018

Airflow obstruction and exercise

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3651265

7 July 2018

Pharmacologic interventions in chronic obstructive pulmonary disease: bronchodilators

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3651265

7 July 2018

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3651265

7 July 2018

Risk of tuberculosis from exposure to tobacco smoke: a systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3651265

7 July 2018

The MCID of the transition dyspnea index is a total score of one unit

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3651265

7 July 2018

Measuring the effects of COPD on the patient

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3651265

7 July 2018

Understanding research synthesis (meta-analysis).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3651265

7 July 2018

Meta-analysis in clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3651265

7 July 2018

Efficacy of indacaterol 75 μg once-daily on dyspnea and health status: results of two double-blind, placebo-controlled 12-week studies

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-13-26

21 January 2018

Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-13-26

21 January 2018

Meaningful effect size and patterns of response of the transition dyspnea index

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-13-26

21 January 2018

Minimal important difference of the transition dyspnoea index in a multinational clinical trial

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-13-26

21 January 2018

Indacaterol once-daily is equally effective dosed in the evening or morning in COPD.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-13-26

21 January 2018

Long-term safety and efficacy of indacaterol, a long-acting β₂-agonist, in subjects with COPD: a randomized, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-13-26

21 January 2018

Once-daily indacaterol versus twice-daily salmeterol for COPD: a placebo-controlled comparison

1 reference

https://pubmed.ncbi.nlm.nih.gov/23617268

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes

1 reference

https://pubmed.ncbi.nlm.nih.gov/23617268

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of indacaterol on exercise endurance and lung hyperinflation in COPD

1 reference

https://pubmed.ncbi.nlm.nih.gov/23617268

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of indacaterol on dynamic lung hyperinflation and breathlessness in hyperinflated patients with COPD

1 reference

https://pubmed.ncbi.nlm.nih.gov/23617268

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of indacaterol 150 and 300 µg in chronic obstructive pulmonary disease patients from six Asian areas including Japan: a 12-week, placebo-controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/23617268

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2466-13-26

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34686851&oldid=2196947617"